Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus

Cellular Pharmacokinetics of the Novel Biaryloxazolidinone Radezolid in Phagocytic Cells: Studies with Macrophages and Polymorphonuclear Neutrophils

(2010) S. Lemaire et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone

(2010) B. J. Morrow et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of the Investigational Fluoroquinolone Finafloxacin against Ciprofloxacin-Sensitive and -Resistant Acinetobacter baumannii Isolates

(2010) P. G. Higgins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes

(2010) Pierre Baudoux et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Study of Antibiotic Combinations

(2009) H. A. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages

(2009) S. Lemaire et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains

(2009) H. A. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Staphylococcal Alpha-Toxin Is Not Sufficient To Mediate Escape from Phagolysosomes in Upper-Airway Epithelial Cells

(2009) B. Giese et al.   INFECTION AND IMMUNITY

Staphylococcus aureus: new evidence for intracellular persistence

(2009) Christian Garzoni et al.   TRENDS IN MICROBIOLOGY

Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases

(2008) M. T. Black et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis

(2008) S. Lemaire et al.   CLINICAL MICROBIOLOGY AND INFECTION